Lotus Eye Hospital And Institute Limited has scheduled a meeting of its Board of Directors for Tuesday, May 26, 2026. The primary agenda for the meeting is to consider and approve the standalone audited financial results of the company for the quarter and year ended March 31, 2026.

The intimation was made in compliance with Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations, 2015. The board will review the financial performance for the specified period during this session.

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prevention of Insider Trading, the trading window for the company's securities remains closed. The window is scheduled to reopen 48 hours after the declaration of the aforementioned financial results.

Meeting Details

The following table outlines the key details regarding the upcoming board meeting:

The company has informed the stock exchanges regarding the schedule. Shareholders and market participants are advised to take note of the meeting date and the subsequent reopening of the trading window.

Lotus Eye Hospital And Institute Limited has filed its quarterly compliance certificate with stock exchanges and depositories, confirming adherence to SEBI regulations for securities dematerialization during Q4FY26.

Regulatory Compliance Certificate

The company submitted the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, dated April 06, 2026. This quarterly filing covers the period ended March 31, 2026, ensuring transparency in the dematerialization process.

Dematerialization Process Confirmation

The certificate confirms that securities received for dematerialization have been properly processed according to regulatory requirements. Key compliance aspects include:

• Securities mutilated and cancelled after due verification
• Depository name substituted in company records as registered owner
• Process completed within 15 days of certificate receipt
• Details furnished to stock exchanges as required

Stock Exchange Listing Compliance

Lotus Eye Hospital confirmed that dematerialized securities remain listed on the same stock exchanges where earlier issued securities are traded. This ensures continuity of trading and maintains investor access to the company's shares.

Registrar Verification

MUFG Intime India Private Limited, serving as the company's Registrar and Share Transfer Agent, provided certification supporting the compliance filing. The registrar confirmed proper handling of securities received from depository participants during the quarter, with appropriate acceptance or rejection procedures followed.

The filing was signed by Prathish S, Company Secretary & Compliance Officer, demonstrating the company's commitment to maintaining regulatory standards and protecting investor interests through proper dematerialization procedures.